John J. Toole
Profile
John J.
Toole has been Senior Vice President of Corporate Development since March 2008.
He joined Gilead in April 1990 as Director of Molecular and Cellular Biology and was promoted to Vice President-Biology in May 1996, Vice President-Clinical Research in 1998 and Senior Vice President-Clinical Research in August 2003.
Dr. Toole was Founding Scientist of Genetics Institute, Inc. He received a PhD in Molecular Biology from the State University of New York at Buffalo and an MD from the Stanford University School of Medicine.
Former positions of John J. Toole
| Companies | Position | End |
|---|---|---|
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | - |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | - |
Training of John J. Toole
| State University of New York at Buffalo | Doctorate Degree |
| Stanford University | Doctorate Degree |
Experiences
Positions held
Linked companies
| Listed companies | 1 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- John J. Toole
